Health and Human Services Secretary Sylvia Burwell on Thursday said the federal government should be able to negotiate drug prices for high-cost and specialty drugs.
“One of the most important tools that we could gain would be an ability to negotiate,” Burwell said at the Atlantic's Washington Ideas Forum.
